Showing results (61-70 of 617) with videos related to
Sort By:
Pageof 62
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Evolving Therapies in Acute Myeloid Leukemia: Progress at Last?Daniel J DeAngelo, Eytan M Stein, Farhad RavandiTherapeutic Advances in Hematology|April 23, 2013
Next-generation sequencing in hematologic malignancies: what will be the dividends?Jason D Merker, Anton Valouev, Jason GotlibCurrent Hematologic Malignancy Reports|February 20, 2016
How We Identify and Manage Patients with Inadequately Controlled Polycythemia VeraAndreas Reiter, Claire HarrisonFuture Oncology (London, England)|September 8, 2025
How I treat Ph+ acute lymphoblastic leukemiaMelanie Castro-Mollo, Daniel J DeAngelo, Marlise R LuskinActa Haematologica|June 10, 2025
Treatment of Older Adults with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic LeukemiaLourdes M Mendez, Daniel J DeAngelo, Marlise R LuskinAmerican Journal of Ophthalmology|March 5, 2003
Resolution of leukemic retinopathy following treatment with imatinib mesylate for chronic myelogenous leukemiaJohn B Christoforidis, Daniel J DeAngelo, Donald J D'AmicoJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2018
New Approaches to the Management of Adult Acute Lymphoblastic LeukemiaRenato Bassan, Jean-Pierre Bourquin, Daniel J DeAngelo, et al.Current Hematologic Malignancy Reports|October 7, 2017
Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid LeukemiaKim-Hien T Dao, Jeffrey W Tyner, Jason GotlibBest Practice & Research. Clinical Haematology|June 20, 2006
Eosinophilic disorders: molecular pathogenesis, new classification, and modern therapyJason Gotlib, N C P Cross, D Gary GillilandBlood|September 11, 2004
After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignanciesMartha Wadleigh, Daniel J DeAngelo, James D Griffin, et al.Pageof 62